Pre-and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Leukemia, 2016 - nature.com
Abstract Measurable ('minimal') residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied …
被引用次数：191 相关文章
[HTML] nih.gov

[HTML][HTML] Pre-and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - Leukemia, 2016 - ncbi.nlm.nih.gov
Abstract Measurable (“minimal”) residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied …

Pre-and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Measurable ('minimal') residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied …
[PDF] researchgate.net

[PDF][PDF] Pre-and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - Leukemia, 2016 - researchgate.net
Abstract Measurable (“minimal”) residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied …

Pre-and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia.

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - Leukemia, 2016 - europepmc.org
Abstract Measurable (“minimal”) residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied …

Pre-and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - Leukemia, 2016 - go.gale.com
Measurable ('minimal') residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) Identifies adults with AML at risk of poor outcomes. Here, we studied …

[引用][C] Pre-and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - Leukemia, 2016 - cir.nii.ac.jp
Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via
multiparameter flow cytometry in adult acute myeloid leukemia | CiNii Research CiNii 国立 …

Pre-and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia.

Y Zhou, M Othus, D Araki, BL Wood, JP Radich… - Leukemia, 2016 - europepmc.org
Abstract Measurable (“minimal”) residual disease (MRD) before or after hematopoietic cell
transplantation (HCT) identifies adults with AML at risk of poor outcomes. Here, we studied …